Why React4life?
By a scientist team, who think as biologists and act as biomedical engineers, to technology to enable the researchers transforming their testing concept in concrete programs, providing an in vitro human systemic platform that allows the use of clinically-relevant size tissue models and physiological fluidic environments.
Read more about us
Reliable
Perform realistic, controlled and reproducible tests in a 3D human systemic environment.
Efficient
Save time and money, turning what you use into disposable MIVO device, which adds human and systemic benefits to your tests.
Customizable
Keep your cells and tissues, use your protocol assays, move on MIVO platform for novel testing needs.
Cruelty free
Contribute to a sustainable cruelty free future.
The biology in lab and in REAL life
Science shows that tests carried out in 2D-standard assays are too simplistic and don’t represent the complexity of real tissues. Moreover, such tests are typically executed under static conditions, although biological life is dynamic: this leads to errors and lack of outcome reliability.
From the excellence of the Italian research, a team of scientists with international collaborations has designed MIVO®, a biology driven technology that put together 3D tissues and the fluidics governing biological processes.
Testimonial
«I appreciate most from the collaboration with the React4life team is the desire to understand what our needs are and not to travel on parallel tracks but on tracks that intersects with the sharing of needs and the integration of mutual skills»
Researcher and professor at CEBR, Center of Excellence for the study of molecular mechanisms of communication between cells: from basic research to the clinicLead Editor per lo special issue “Immunotherapy in the treatment of human solid tumor: basic and translational aspect” (Journal of Immunology Research: https://www.hindawi.com/journals/jir/si/142926/cfp/)
Our clients
NEWS
“My passion has always been to do something that would generate a concrete and immediate impact on the society”.
Interview with Future and Emerging Technologies Innovator Silvia Scaglione from the Eruopean Commission website https://ec.europa.eu/digital-single-market/en/news/interview-future-and-emerging-technologies-innovator-silvia-scaglione which we thanks. Silvia Scaglione is specialist in bioengineering. Since 2010, she is a permanent researcher at the Italian National Research Council (CNR) and head of the Labor atory of Tissue Engineering CNR-IEIIT in Genoa. She is also founder, president and chief scientist of React4Life, an innovative biotech start-up. Currently, Silvia Scaglione is coordinating the B2B project, which is supported by the FET Open programme under the Horizon 2020 Framework. B2B (in full title “Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind [...]
React4life is proudly supported by
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 827655
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 801159
